Biosergen
0.316 SEK -9.46%Be the first to follow this company
Biosergen is a biotechnology company. The company specializes in the research and development of various pharmaceuticals. The product portfolio includes, for example, the company's product BSG005, a fungicidal pharmaceutical in the clinical phase. In addition to the main business, service and associated ancillary services are also offered. The company operates in Norway. Biosergen was founded in 2004 and is headquartered in Solna.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
BIOSGN
Daily low / high price
0.308 / 0.349
SEK
Market cap
44.99M SEK
Turnover
29.48K SEK
Volume
91K
Financial calendar
Interim report
2024-05-31
General meeting
2024-06-14
Interim report
2024-08-30
Interim report
2024-11-29
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Östersjöstiftelsen | 45.0 % | 45.0 % |
Rosetta Capital IV Sarl | 17.6 % | 17.6 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Biosergen AB: Biosergen resolves on a directed issue to underwriters in connection with the completed rights issue
Biosergen AB: Biosergen announces the outcome in the rights issue
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools